Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors

@inproceedings{Wang2016LossOC,
  title={Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors},
  author={Junhui Wang and Qianshan Ding and Hiroaki Fujimori and Akira Motegi and Yoshio Miki and Mitsuko Masutani},
  booktitle={Oncotarget},
  year={2016}
}
  • Junhui Wang, Qianshan Ding, +3 authors Mitsuko Masutani
  • Published in Oncotarget 2016
  • Medicine
  • Breast cancer is one of the leading causes of death worldwide, and therefore, new and improved approaches for the treatment of breast cancer are desperately needed. CtIP (RBBP8) is a multifunctional protein that is involved in various cellular functions, including transcription, DNA replication, DNA repair and the G1 and G2 cell cycle checkpoints. CtIP plays an important role in homologous recombination repair by interacting with tumor suppressor protein BRCA1. Here, we analyzed the expression… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 16 CITATIONS

    Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa Cells

    VIEW 5 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED

    Prognosis value of RBBP8 expression in plasma cell myeloma

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Antiproliferative activity of synthesized some new benzimidazole carboxamidines against MCF-7 breast carcinoma cells

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 51 REFERENCES

    The DNA damage response and cancer therapy

    VIEW 1 EXCERPT
    HIGHLY INFLUENTIAL